Biostar Pharmaceuticals, Inc. (BSPM)

Market Cap	264.00
Revenue (ttm)	317.79K
Net Income (ttm)	934.35K
Shares Out	2.64M
EPS (ttm)	0.34
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,400
Average Volume	161
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-4,376.59
RSI	88.96
Earnings Date	n/a

About Biostar Pharmaceuticals

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets over-the-counter (OTC) and prescription pharmaceutical products for various diseases and conditions in the People’s Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides 12 other OTC products and 17 prescription-based pharmaceuticals. The company’s OTC products also comprise Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore thro...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 200
• Stock Exchange: OTCMKTS
• Ticker Symbol: BSPM

Financial Performance

In 2016, Biostar Pharmaceuticals's revenue was $2.38 million, a decrease of -91.21% compared to the previous year's $27.13 million. Losses were -$5.70 million, -77.31% less than in 2015.